In Psoriasis Lesional Skin the Type I Interferon Signaling Pathway Is Activated, Whereas Interferon-α Sensitivity Is Unaltered
- 1 January 2004
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 122 (1), 51-60
- https://doi.org/10.1046/j.0022-202x.2003.22113.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2)The Journal of Pathology, 2002
- Interferon-κ, a Novel Type I Interferon Expressed in Human KeratinocytesPublished by Elsevier BV ,2001
- Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesionsJCI Insight, 1999
- Immunomodulation and Therapeutic Effects of the Oral Use of Interferon-alpha: Mechanism of ActionJournal of Interferon & Cytokine Research, 1999
- The Type I Interferon System Is Locally Activated in Psoriatic LesionsJournal of Interferon Research, 1994
- IL‐1 ALPHA‐INDUCED EXPRESSION OF ICAM‐1 ON CULTURED HYPERPROLIFERATIVE KERATINOCYTES: SUPPRESSION BY ANTIPSORIATIC DIMETHYL‐FUMARATEInternational Journal of Dermatology, 1994
- The effect of anti-CD4 monoclonal antibody treatment on immunopathological changes in psoriatic skinJournal of Dermatological Science, 1994
- Defining criteria for autoimmune diseases (Witebsky's postulates revisited)Immunology Today, 1993
- Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-α) in allergic contact dermatitis (rhus dermatitis)British Journal of Dermatology, 1991
- Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.The Journal of cell biology, 1988